Pharmacokinetic-Moedeling
Showing 26 - 50 of 6,082
HIV-1 Trial in Beijing (1 mg CL-197 capsules or CL-197 , 10 mg CL-197 capsules or CL-197 , 30 mg CL-197 capsules or CL-197 )
Recruiting
- HIV-1
- 1 mg CL-197 capsules or CL-197 placebo
- +4 more
-
Beijing, Beijing, ChinaThe Fifth Medical Center of Chinese PLA General Hospital
Jul 12, 2023
Pharmacokinetics Trial (WCK 2349 Oral, Placebo Oral)
Completed
- Pharmacokinetics
- WCK 2349 Oral
- Placebo Oral
- (no location specified)
Nov 28, 2022
Healthy Volunteers Trial in Miami, Baltimore (GSBR-1290 (Capsule/Tablet), GSBR-1290, Placebo)
Recruiting
- Healthy Volunteers
- GSBR-1290 (Capsule/Tablet)
- +3 more
-
Miami, Florida
- +2 more
Nov 14, 2023
Healthy Volunteer Trial in Wuhan (GFH312 100 mg, GFH312 200 mg, GFH312 120mg)
Completed
- Healthy Volunteer
- GFH312 100 mg
- +3 more
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023
Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- STSA-1301 subcutaneous injection
- Placebo
-
Beijing, Chaoyang District, ChinaBeijing Ditan Hospital,Capital Medical University
Nov 28, 2023
Heathy Participants Trial (Treatment A (BDA MDI HFO), Treatment B (BDA MDI HFA))
Not yet recruiting
- Heathy Participants
- Treatment A (BDA MDI HFO)
- Treatment B (BDA MDI HFA)
- (no location specified)
Nov 15, 2023
Hyperlipidemias Trial in Seoul (AD-104-A)
Not yet recruiting
- Hyperlipidemias
-
Seoul, Jongno-gu, Korea, Republic ofSeoul National University Hospital
Jan 26, 2023
Hypertension, Diabetes, Type 2 Trial in Incheon (BR1019-1, BR1019-2, BR1019-1 + BR1019-2)
Recruiting
- Hypertension
- Diabetes Mellitus, Type 2
- BR1019-1
- +2 more
-
Incheon, Korea, Republic ofInha University Hospital
May 16, 2023
Mechanically Ventilated Patients Trial in Wuhan (Remimazolam besylate)
Not yet recruiting
- Mechanically Ventilated Patients
- Remimazolam besylate
-
Wuhan, Hubei, ChinaWuhan Union Hospital
Nov 23, 2023
Climacteric Syndrome, Menopause, Hypoestrogenism Trial in Santos (s.c 25 mg estradiol pellet)
Recruiting
- Climacteric Syndrome
- +2 more
- s.c 25 mg estradiol pellet
-
Santos, São Paulo, BrazilIrmandade Da Santa Casa De Misericórdia De Santos - Science Vall
Nov 13, 2023
Healthy Trial in Miami (CORT125134 150 mg, CORT125134 250 mg, CORT125134 dose to be determined)
Completed
- Healthy
- CORT125134 150 mg
- +2 more
-
Miami, FloridaQuotient Sciences, Miami, Inc.
Oct 17, 2023
Healthy Trial in Zürich (Dimethyltryptamin (DMT) & Harmine)
Not yet recruiting
- Healthy
- Dimethyltryptamin (DMT) & Harmine
-
Zürich, ZH, SwitzerlandUniversity Hospital of Psychiatry Zurich
Apr 13, 2023
COVID-19 Pneumonia Trial in Changchun (GST-HG171 Tablets)
Recruiting
- COVID-19 Pneumonia
- GST-HG171 Tablets
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 26, 2023
COVID-19 Pneumonia Trial in Changchun (GST-HG171 Tablets)
Completed
- COVID-19 Pneumonia
- GST-HG171 Tablets
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 26, 2023
Tumors Trial in Bengbu (The test olaparib tablet (T), The reference olaparib tablet (R))
Completed
- Neoplasms
- The test olaparib tablet (T)
- The reference olaparib tablet (R)
-
Bengbu, Anhui, ChinaThe First Affiliated Hospital of Bengbu Medical College
May 15, 2023
Opioid Dependence, Alcohol Dependence Trial (Vivitrol Injectable Product, IVL3004)
Not yet recruiting
- Opioid Dependence
- Alcohol Dependence
- Vivitrol Injectable Product
- IVL3004
- (no location specified)
Nov 10, 2022
Healthy Trial in Berlin, Hamburg (LY06006 (Denosumab Biosimilar), US-Prolia (Denosumab), EU-Prolia)
Completed
- Healthy
- LY06006 (Denosumab Biosimilar)
- +2 more
-
Berlin, Germany
- +1 more
Oct 18, 2023
Healthy Subject Trial in Seoul (Ursodeoxycholic Acid 250 Mg Oral Tablet)
Completed
- Healthy Subject
- Ursodeoxycholic Acid 250 Mg Oral Tablet
-
Seoul, Korea, Republic Of, Korea, Democratic People's Republic ofKyung Hee University Medical Hospital
Apr 16, 2023
Patients With Mild or Moderate Hepatic Impairment Trial in Tokyo (TS-142 5 mg)
Recruiting
- Patients With Mild or Moderate Hepatic Impairment
- TS-142 5 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Dec 27, 2022
Healthy Trial in Nanjing (SHR8554;Itraconazole)
Completed
- Healthy
-
Nanjing, Jiangsu, ChinaAffiliated Drum Tower Hospital, Medical School of Nanjing Univer
Jun 26, 2023